Aya Yamaguchi

Aya Yamaguchi

Auto-generated profile, based on publicly available information

Aya Yamaguchi

Department of Allergy and Respiratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
KYKoichi Yamaguchi
Koichi Yamaguchi
TNTakahito Nakajima
Takahito Nakajima
AYAya Yamaguchi
Aya Yamaguchi
MIMiki Itai
Miki Itai
YOYuji Onuki
Yuji Onuki
TMToshitaka Maeno
Toshitaka Maeno

23 May 2015 in Respiratory Medicine Case Reports
Verified
Journal Article
Open access
HMHiroaki Masubuchi
Hiroaki Masubuchi
TMTOSHITAKA MAENO
TOSHITAKA MAENO
MUMegumi Uchida
Megumi Uchida
SKShunichi Kono
Shunichi Kono
MSMasafumi Suzuki
Masafumi Suzuki
MKMasahiko Kurabayashi
Masahiko Kurabayashi
A 47-year-old female with no history of previous illnesses developed cerebral infarction and was diagnosed with lung cancer, specifically EGFR mutation-positive adenocarcinoma, and Trousseau syndrome. The patient's response to anticoagulant therapy with non-fractionated heparin was very poor; however we were able to control the thrombosis with chemotherapy. She survived for one year and 10 months following treatment with gefitinib, CBDCA + PEM and erlotinib, without recurrence of thrombosis. Trousseau syndrome carries a poor prognosis and controlling thrombosis is difficult. In this case, the administration of anticancer therapy allowed use to control the patient's thrombosis. Therefore, this case highlights the importance of treating cancer in patients with Trousseau syndrome. In addition, the FDP and D-dimer levels changed in parallel with changes in the CEA level, which suggests that the activity of cancer is related to an internal thrombotic tendency. Hence, changes in the FDP and D-dimer values are associated with the efficacy of treatment with EGFR tyrosine kinase inhibitors and chemotherapy and may function as markers of recurrence.

4 October 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
KYKoichi Yamaguchi
Koichi Yamaguchi
AYAya Yamaguchi
Aya Yamaguchi
MIMasashi Ito
Masashi Ito
IWIkuo Wakamatsu
Ikuo Wakamatsu
MIMiki Itai
Miki Itai
TMTOSHITAKA MAENO
TOSHITAKA MAENO

30 May 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
KYKoichi Yamaguchi
Koichi Yamaguchi
AYAya Yamaguchi
Aya Yamaguchi
MIMiki Itai
Miki Itai
YOYuji Onuki
Yuji Onuki
YSYuki Shin
Yuki Shin
TMTOSHITAKA MAENO
TOSHITAKA MAENO

1 December 2018 in Journal of Cardiology Cases
Verified
Journal Article
Closed access
SNShun Nakamura
Shun Nakamura
TTTakeshi Tokunaga
Takeshi Tokunaga
AYAya Yamaguchi
Aya Yamaguchi
TKToshikazu Kono
Toshikazu Kono
KKKensuke Kasano
Kensuke Kasano
KHKenzo Hirao
Kenzo Hirao